Stone and Laser Therapies Post-Market Study
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
⁃ For urinary tract procedure cohort:
• Subject intends to undergo diagnostic and/or therapeutic urinary tract procedure with qualified BSC device(s)
• Subject is willing and able to complete all follow-up visits
⁃ For BPH cohort:
• Subject is ≥ 40 years of age
• Subject with a diagnosis of benign prostatic hyperplasia (BPH) with lower urinary tract symptoms
• Subject intends to undergo BPH treatment with qualified BSC device(s)
• Subject is willing and able to complete all follow-up visits